Ottawa Hospital to manufacture COVID-19 vaccines
March 17, 2021
OTTAWA – The Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC) plans to manufacture three COVID-19 vaccines for human clinical trials, filling a critical gap in Canada’s vaccine manufacturing capacity. “If we’re going to vaccinate every person in Canada and around the world, we need more vaccines, more research and more manufacturing capacity,” said Dr. Duncan Stewart (pictured), executive vice-president of research at The Ottawa Hospital and professor of medicine at the University of Ottawa. Read More